{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-26-000002","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.538839+00:00","generated_at":"2026-05-16T10:46:32.543933+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"FTC injunction blocks Edwards' JenaValve acquisition; Edwards raises FY2026 EPS guidance to $2.90-$3.05","bullets":["US District Court grants FTC motion for injunction blocking Edwards' acquisition of JenaValve; deal terminated.","Edwards revises FY2026 adjusted EPS guidance upward to $2.90-$3.05 from $2.80-$2.95.","Edwards disagrees with ruling, remains committed to AR therapy; advancing SOJOURN valve and JOURNEY trial.","Additional updates expected at Q4 earnings call in February."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-26-000002","json":"https://secwatch.observer/filing/0001099800-26-000002.json","markdown":"https://secwatch.observer/filing/0001099800-26-000002.md","text":"https://secwatch.observer/filing/0001099800-26-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000002/0001099800-26-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000002/ew-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:46:32.543933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}